RG7834
RG7834 (RO 7020322) is a potent, orally bioavailable small-molecule inhibitor of hepatitis B virus, demonstrating low nanomolar IC50 values against HBsAg, HBeAg, and HBV DNA in dHepaRG cell assays. It serves as a valuable research tool for investigating HBV replication mechanisms and evaluating antiviral strategies in both in vitro and in vivo models.
Product Specifications
CAS Number
2072057-17-9
Product Name Alternative
Inhibit, HBsAg, HBV, HBV DNA, HBeAg, Hepatitis B virus, Inhibitor, RO 7020322, RO7020322, RO-7020322, RG 7834, RG7834, RG-7834
Field of Research
Infectious Disease & Virology
Purity
98.00% (May vary between batches)
Solubility
DMSO:125 mg/mL (311.37 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (9.96 mM)
Smiles
COCCCOc1cc2C[C@@H] (C (C) C) n3cc (C (O) =O) c (=O) cc3-c2cc1OC
Molecular Formula
C22H27NO6
Molecular Weight
401.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Parkin, phosphorylated (Ser378) (AR-JP, E3 Ubiquitin Protein Ligase Parkin, FRA6E, LPRS2, Parkinson Disease (Autosomal Recessive, Juvenile) 2, Parkinson Disease Protein 2, Parkinson Juvenile Disease Protein 2, PARK2, PRKN 2, PRKN, PDJ, RING-type E3 Ubiquitin-protein Ligase, Ubiquitin E3 Ligase PRKN) (PE) discontinued
Lentiviral mouse Pmm2 shRNA (UAS) - Lentiviral mouse Pmm2 shRNA (UAS) plasmid
